Search Results 481-490 of 15989 for saffron dosage

  1. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma. A ...

  2. Clinical trials - Oncology (Medical)

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  3. Clinical trials - Oncology (Medical)

    To determine the maximally tolerated dose (MTD) of intratumoral administration of an Edmonston strain measeles virus genetically engineered to express NAP ...

  4. Obstetrics and Gynecology - Clinical trials

    ... dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma. Patient ...

  5. Clinical trials - Oncology (Medical)

    Rochester, Minn., Jacksonville, Fla. This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients ...

  6. A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer - Mayo Clinic

    ... doses of eFT508 in combination with a fixed dose of avelumab to determine the maximum tolerated dose (MTD) of eFT508 and to select a recommended dose for Part 2 ...

  7. Neurology - Clinical trials

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  8. A Study to Compare Whole Brain Radiotherapy and Memantine to Stereotactic Radiosurgery vs. Stereotactic Radiosurgery Alone to Treat Patients with Cancer That Has Spread to the Brain After Earlier Stereotactic Radiosurgery - Mayo Clinic

    Stereotactic radiosurgery delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue.

  9. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    Part 1 is a dose escalation phase to determine the maximum tolerated dose (MTD) of INCB040093, a PI3Kδ inhibitor, or a tolerated, pharmacologically active dose ...

  10. STI-3031 Through Sofusa DoseConnect for Treatment of Intransit Melanoma - Mayo Clinic

    About this study. The purpose of this phase trial is to identify the best dose of STI-3031 that can be administered through the DoseConnect device in ...